When compared with Whites, Black-Americans may have a 40% higher incidence venous thromboembolism (VTE) incidence. However, whether other VTE characteristics and risk factors vary by race is uncertain. To compare demographic and baseline characteristics among White-and Black-Americans with VTE, we used data prospectively collected from consecutive consenting adults enrolled in seven Centers for Disease Control (CDC) Thrombosis and Hemostasis Centers from August 2003 to March 2009. These characteristics were compared among Whites (n 5 2002) and Blacks (n 5 395) with objectively diagnosed VTE, both overall, and by age and gender. When compared with Whites, Blacks had a significantly higher proportion with pulmonary embolism (PE), including idiopathic PE among Black women, and a significantly higher proportion of Blacks were women. Blacks had a significantly higher mean BMI and a significantly lower proportion with recent surgery, trauma or infection, family history of VTE, and documented thrombophilia (solely from reduced factor V Leiden and prothrombin G20210A prevalence). Conversely, Blacks had a significantly higher proportion with hypertension, diabetes mellitus, chronic renal disease and dialysis, HIV, and sickle cell disease. When compared with White women, Black women had a significantly lower proportion with recent oral contraceptive use or hormone therapy. We conclude that Whites and Blacks differ significantly regarding demographic and baseline characteristics that may be risk factors for VTE. The prevalence of transient VTE risk factors and idiopathic VTE among Blacks appears to be lower and higher, respectively, suggesting that heritability may be important in the etiology of VTE among Black-Americans. Am. J. Hematol. 85:467-471, 2010. V V C 2010 Wiley-Liss, Inc.
Introduction
Most epidemiologic studies of venous thromboembolism (VTE) risk factors have been conducted within White-American and -European populations [1] [2] [3] [4] . However, when compared with Whites, Black-Americans appear to have a higher risk for [5, 6] and incidence of VTE [7] [8] [9] [10] . Two single-nucleotide polymorphisms, factor V Leiden (G1691A) and prothrombin G20210A, have been identified as risk factors for deep vein thrombosis (DVT) and pulmonary embolism (PE) in Europeans and White-Americans, [11] [12] [13] [14] [15] [16] but not Black-Americans [6, 17, 18] . We hypothesized that the apparent higher VTE incidence among Blacks might be due to an increased prevalence of known VTE risk factors. To test this hypothesis, we compared demographic and baseline clinical characteristics from White-and Black-Americans with objectively diagnosed VTE who were seen in one of the seven CDC Thrombosis and Hemostasis Research and Prevention Network centers.
Methods

Study setting, population, and design
The study setting was the seven centers (the University of Michigan Hemophilia and Coagulation Disorders Program, Ann Arbor, MI; the Thrombophilia Program, UNC, Chapel Hill, NC; the Michigan State University Comprehensive Center for Bleeding Disorders, East Lansing, MI; the Wayne State University, Detroit, MI; the Mountain States Regional Hemophilia and Thrombosis Center, Aurora, CO; the Duke Hemostasis and Thrombosis Center, Durham, NC; and the New Jersey Regional Hemophilia Program, UMDNJ-Robert Wood Johnson University Hospital, New Brunswick, NJ) within the CDC Thrombosis and Hemostasis Centers Research and Prevention Network [19] with substantial numbers of Black-American patients with VTE. Patients and/or their families attending one of the seven centers for medical care, or seen as an inpatient consult or referral, were approached by local center staff for study participation regardless of age, gender, or race. For consenting patients, study participation consisted of center staff completion of a standardized data collection form for the initial and all subsequent visits. In the case of pediatric patients, consent was obtained from the parent or legal guardian as well as an assent for children older than 7 years of age. Data were entered into a web-based registry maintained on a secure server within the Division of Blood Disorders at the CDC. Patient identifying information, including name, address, physician, and insurance carrier, remained within a locally housed secure database at each center. For purposes of confidentiality, only the study identification number and registry information were sent to the registry at the CDC. The registry, study protocol, and other study materials are approved annually by the Institutional Review Boards at each of the participating sites and at the CDC.
The registry began patient enrollment in August 2003. For this study, the population was consenting, self-identified White-and Black-American adults of non-Hispanic or non-multiracial ethnicity with objectively
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diagnosed DVT and/or PE who were enrolled at one of the seven centers from August 2003 to March 2009, and for whom registry data were available. A DVT was categorized as objectively diagnosed when symptoms or signs of acute DVT were present, and the diagnosis was confirmed by venography, compression venous duplex ultrasonography, impedance plethysmography, computed tomographic venography, or magnetic resonance imaging. A PE was categorized as objectively diagnosed when symptoms and/or signs of acute PE were present, and the diagnosis was confirmed by pulmonary angiography, a ventilation/perfusion lung scan interpreted as high probability for PE, computed tomographic pulmonary angiography, or magnetic resonance imaging.
Using a cross-sectional study design, we queried the CDC registry for demographic and clinical characteristic data collected at the initial visit for each patient age 18 years or older at enrollment and compared these data among Whites and Blacks.
Measurements
Data collected at the initial visit included patient demographic and clinical characteristics, referral patterns, reasons for and details of the visit (including providers seen, concurrent medical and lifestyle conditions, laboratory and radiological tests ordered, educational materials received), diagnoses, and treatments prescribed.
Analyses
For patients with objectively diagnosed VTE, demographic, baseline, and clinical characteristics were compared among White-and BlackAmerican patients, age 18 and older, both overall, and by age and gender. All analyses were performed using SAS 9.2 (SAS, Institute Cary, NC). For categorical variables of interest, univariate frequencies were generated to calculate the prevalence and compared using Pearson's v 2 and two-tailed P-values, and in the case of small cell sizes (5), two-tailed Fisher's exact P-values are reported. For continuous variables, mean values were computed and differences were tested using Student's t-test.
Definition of variables
The presence of medical comorbidities was defined as the patient having the condition within the 3 months prior to the VTE event. The presence of thrombophilia was defined by diagnosis of an inherited or acquired thrombophilia (factor V Leiden, prothrombin G20210A mutation, antiphospholipid syndrome, antithrombin, protein C or protein S deficiency) at baseline or after subsequent evaluation by a CDC Thrombosis and Hemostasis Research and Prevention Center. For all patients with antiphospholipid antibodies and for most patients with an inherited thrombophilia, the presence of thrombophilia was confirmed by laboratory testing performed at a CDC Center. The updated Sapporo criteria [20] were used for diagnosis of antiphospholipid syndrome. ''Idiopathic'' VTE was defined as VTE in the absence of recent surgery, trauma, infection, pregnancy or postpartum period, oral contraceptive use or hormone therapy; active cancer; or HIV.
To assess potential referral bias, the distance from patient residence to Network center was compared among White-and Black-American patients with VTE, both overall and by center. Distances represent miles from the centroid of the home residence zip code to the centroid of the Center's zip code. Mean distance was calculated and then compared between the groups using Student's t-test.
Results
Of the 4,831 patients with nonbleeding disorders enrolled in the CDC Registry from August 2003 to March 2009, 3,879 were of age 18 years or older upon enrollment and self-identified as White-or Black-American of non-Hispanic or nonmultiracial ancestry. Of these, 2,397 had at least one objectively diagnosed VTE event; 2,002 were White-and 395 were Black-Americans. The distribution of White-and BlackAmerican VTE cases by center is shown in Table I .
The mean ± SD (range) age among Whites and Blacks with VTE at enrollment did not differ significantly (47.7 ± 15.7 [18, 91] vs. 46.1 ± 15.6 [18, 86] years). When compared with Whites, a significantly higher proportion of Blacks were of female gender (70.6% vs. 60.6%; P 5 0.0002). The mean body mass index was higher among Blacks (32.9 kg/m 2 vs. 29.9 kg/m 2 ; P < 0.0001). When compared with Whites, Blacks had a significantly lower proportion with DVT and a significantly higher proportion with PE (Table II) . Otherwise, the distribution of DVT by vein location did not differ significantly by race (Table  III) . The mean ± SD total number of VTE events was marginally but significantly greater among Whites (1.57 ± 1.03 vs. 1.46 ± 0.89; P 5 0.03) but did not differ significantly among White versus Black women or men. The percentage of Whites and Blacks with recurrent VTE also did not differ significantly (34.9% vs. 30.7%; P 5 0.11). The mean ± SD ages at first VTE, DVT, and PE were not significantly different by race or by gender within race.
Among baseline characteristics previously identified as VTE risk factors, when compared with Whites, Blacks had a significantly lower proportion with recent surgery, trauma or infection, and a significantly higher proportion with HIV and sickle cell disease (Table IV) . Among women, Black women had a significantly lower proportion with recent oral contraceptive use when compared with White women. Among women 40 years of age, Black women had a significantly lower proportion with recent hormone therapy. The proportion of patients with active cancer or autoimmune disease did not differ by race. Among all patients with VTE, Blacks had a significantly lower proportion with a family history of VTE and with a diagnosed thrombophilia. However, the lower proportion of thrombophilia among Blacks was almost solely due to the virtual absence of the factor V Leiden and prothrombin G20210A mutations (Table  V) . The proportion with antiphospholipid syndrome and deficiency of antithrombin, protein C, and protein S did not differ significantly by race. Although the proportion with idiopathic VTE did not differ by race, Blacks had significantly lower and higher proportions of idiopathic DVT and idiopathic PE, respectively (Table IV) . Among other clinical characteristics, when compared with Whites, Blacks had a significantly higher proportion with hypertension, diabetes mellitus, and chronic renal disease and dialysis (Table VI) . The two groups did not differ significantly regarding the proportion with stroke, cerebral palsy, coronary artery disease/myocardial infarction, congenital heart disease, congestive heart failure, peripheral artery disease, or chronic liver disease.
When compared with White women, the distribution of VTE risk factors among Black women varied significantly, with Black women having a significantly lower proportion with recent surgery, trauma or infection, and a significantly higher proportion with HIV infection and sickle cell disease (Table VII) . Black women had a significantly higher proportion of idiopathic PE and a significantly lower proportion of idiopathic DVT. When compared with White men, Black men did not differ significantly regarding recent surgery, trauma, cancer, infection, or autoimmune disease (Table  VII) ; Black men did have a significantly higher proportion with HIV infection and sickle cell disease. The proportion with idiopathic VTE, DVT, or PE did not differ by race among men.
Overall, the mean distance from patient residence to center address (as reflected by ZIP code) was significantly greater for Whites (55.0 miles, range 5 0-3,461 miles) when compared with Blacks (31.6 miles, range 5 0-260 miles; P < 0.0001). For five of the seven centers, the mean distance from patient residence to the center address was significantly greater for White patients with VTE when compared with Black patients with VTE and not significantly different for the other two centers (Table VIII) . When analyzed for distances of >30, >50, and >75 miles from patient residence to center address, the proportion by center for each distance was either significantly greater for White patients with VTE or not significantly different when compared with Black patients with VTE (data not shown).
Discussion
The important findings of our study are that when compared with White patients with VTE, Blacks with VTE had a lower proportion with transient VTE risk factors (i.e., less recent surgery, trauma and infection; and among women, less recent oral contraceptive use and hormone therapy) and a higher proportion with idiopathic PE. Our findings are similar to those of the Genetic Attributes and Thrombosis Epidemiology (GATE) study, a case-control study of risk factors for VTE among White-and African-Americans in which Blacks were more likely to have VTE unrelated to cancer, or recent surgery or immobilization [6] .
Our finding of an increased prevalence of idiopathic PE among Black women is supported by previous work showing a higher incidence of idiopathic PE among Blacks when compared with Whites [8] . Given the poor survival after PE, [21] our finding of an increased prevalence of PE among Blacks (particularly idiopathic PE) is disturbing, especially when coupled with previous reports of increased complications after VTE and higher PE case fatality among Blacks [8, 9, 22, 23] .
Also similar to previous studies, [6, 17, 18] we found a very low prevalence of factor V Leiden and prothrombin G20210A carriers among Blacks with VTE. Although we found other potential VTE risk factors such as sickle cell trait and disease, [24] HIV-infection [25] , and anticardiolipin antibodies [26] to be higher among Blacks when compared with Whites, the prevalence of these disorders among Blacks was low and insufficient to account for the reported higher VTE incidence among Blacks [5, [8] [9] [10] . Blacks had a higher BMI and a higher prevalence of hypertension, diabetes mellitus, and chronic renal disease (including hemodialysis), but the association of these characteristics with VTE is uncertain [3, 5, 27] .
Our findings do not support the hypothesis that the higher VTE incidence among Blacks is due to an increased prevalence of known VTE risk factors. However, we cannot exclude the possibility of as yet unidentified environmental and/or social risks factors in the etiology of VTE among Black-Americans. For many prevalent health conditions, Black-Americans suffer a disproportionate burden of disease including higher incidence, morbidity, and mortality when compared with White-Americans [28] . The higher prevalence of PE among Black-American women in our study may reflect health disparities in VTE as well, including the social factors of access to care and delayed identification of DVT. Alternatively, the biology of VTE among Blacks may increase the proportion [29] [30] [31] [32] [33] [34] our findings suggest that a genetic component may exist in the etiology of VTE among Blacks. In support of this hypothesis, the plasma levels of several procoagulant and anticoagulant factors both vary by race [35] [36] [37] [38] and exhibit substantial heritability [39] [40] [41] [42] [43] . When compared with Whites, Blacks have higher levels of fibrinogen, [35, 36, 38] factor VIII, [37, 38, 44] von Willebrand factor [37, 38, 44] , and plasma fibrin D-dimer [38, 45, 46] , and lower levels of protein C [36] . Moreover, among Blacks, VTE has been associated with increased levels of fibrinogen, [29] factor VIII [47] , and plasma fibrin D-dimer [48] . Although the lower prevalence of a family history of VTE among Blacks when compared with Whites might argue against a heritable component, this observation could also be explained by the frequent incomplete penetrance of inherited thrombophilia [14, [49] [50] [51] .
Our study has important limitations. As there was no control group, we cannot test the characteristics measured in this study as potential VTE risk factors by race. Moreover, as our study was not population based, our findings may not represent the full spectrum of VTE disease occurring in the community. For example, because patients had to live sufficiently long to reach a center, rapidly fatal VTE (and especially fatal PE) cases are under represented as are patients with VTE in chronic care facilities. In addition, each of the seven centers did not contribute equally to the study population. Thus, the findings may be skewed by the one or possibly two centers contributing the most patients to the registry. Finally, we cannot exclude referral bias. In fact, the characteristics of the two racial groups in this study likely do not reflect those of the community. When compared with the population-based studies of predominantly Whites of non-Hispanic ancestry, Whites in this study were younger and had a lower proportion with recent surgery (11.3% vs. 23 
Conclusions
Despite these limitations, the prevalence of common transient or acquired risk factors (i.e., recent surgery, trauma, infection) appears to be lower among AfricanAmerican patients with VTE, while the prevalence of idiopathic VTE (especially idiopathic PE) appears to be higher. We believe these findings support the hypothesis that heritability plays a significant role in the etiology of VTE among Black-Americans. As the carrier frequencies of the two most common inherited polymorphisms associated with VTE (i.e., factor V Leiden, prothrombin G20210A) are extremely low among Black-Americans, we also hypothesize that other as yet unrecognized inherited polymorphisms are associated with VTE in blacks. Such polymorphisms could give important insights into as yet unrecognized pathways that are associated with VTE. 
